Genmab announces progress with Lundbeck collaboration
First pre-clinical milestone met in Lundbeck collaboration
19-Dec-2011 -
Genmab A/S announced it had reached the first pre-clinical milestone in the collaboration with H. Lundbeck A/S, triggering a €1 million payment. Genmab has reached the first milestone in the collaboration with H. Lundbeck A/S to create and develop human antibody therapeutics for disorders of the ...
central nervous system
Genmab
human antibodies
+1